EMA Authorised: Melatonin Neurim (melatonin) — RAD Neurim Pharmaceuticals EEC SARL

View source ↗

Summary

EU authorization of Melatonin Neurim (melatonin) for sleep initiation and maintenance disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sleep Initiation and Maintenance Disorders

Drugs mentioned

• Melatonin Neurim (melatonin)

Snippet

Status: Authorised. Therapeutic area: Sleep Initiation and Maintenance Disorders. MAH: RAD Neurim Pharmaceuticals EEC SARL. Decision date: 14/09/2023